(R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine

ID: ALA482690

Chembl Id: CHEMBL482690

Cas Number: 147057-10-1

PubChem CID: 461307

Max Phase: Preclinical

Molecular Formula: C9H15N6O4P

Molecular Weight: 302.23

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](Cn1cnc2c(N)nc(N)nc21)OCP(=O)(O)O

Standard InChI:  InChI=1S/C9H15N6O4P/c1-5(19-4-20(16,17)18)2-15-3-12-6-7(10)13-9(11)14-8(6)15/h3,5H,2,4H2,1H3,(H2,16,17,18)(H4,10,11,13,14)/t5-/m1/s1

Standard InChI Key:  LWEKFDHXJHJYGB-RXMQYKEDSA-N

Alternative Forms

Associated Targets(Human)

MT2 (2907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MT4 (17854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Porcine endogenous retrovirus (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Feline immunodeficiency virus (139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 302.23Molecular Weight (Monoisotopic): 302.0892AlogP: -0.47#Rotatable Bonds: 5
Polar Surface Area: 162.40Molecular Species: ACIDHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: -5.31CX Basic pKa: 6.56CX LogP: -4.26CX LogD: -3.68
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.53Np Likeness Score: -0.29

References

1. Shi M, Wang X, De Clercq E, Takao S, Baba M..  (2007)  Selective inhibition of porcine endogenous retrovirus replication in human cells by acyclic nucleoside phosphonates.,  51  (7): [PMID:17470654] [10.1128/aac.00212-07]
2. Jansa P, Baszczyňski O, Dračínský M, Votruba I, Zídek Z, Bahador G, Stepan G, Cihlar T, Mackman R, Holý A, Janeba Z..  (2011)  A novel and efficient one-pot synthesis of symmetrical diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities.,  46  (9): [PMID:21664011] [10.1016/j.ejmech.2011.05.040]
3. Krečmerová M, Jansa P, Dračínský M, Sázelová P, Kašička V, Neyts J, Auwerx J, Kiss E, Goris N, Stepan G, Janeba Z..  (2013)  9-[2-(R)-(Phosphonomethoxy)propyl]-2,6-diaminopurine (R)-PMPDAP and its prodrugs: optimized preparation, including identification of by-products formed, and antiviral evaluation in vitro.,  21  (5): [PMID:23375089] [10.1016/j.bmc.2012.12.044]

Source